
    
      The total study duration per subject ranges from 4 to 20 weeks broken down as follows:

        -  screening within 4 weeks before dosing,

        -  follow-up of 4 weeks (28 days) after the single dose of study medication,

        -  prolonged by a maximum of 12 weeks if plasma PK level > Limit Of Quantification (LOQ) at
           Day 28.
    
  